BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 21816613)

  • 1. Removal of primary tumor improves survival in metastatic breast cancer. Does timing of surgery influence outcomes?
    Pérez-Fidalgo JA; Pimentel P; Caballero A; Bermejo B; Barrera JA; Burgues O; Martinez-Ruiz F; Chirivella I; Bosch A; Martínez-Agulló A; Lluch A
    Breast; 2011 Dec; 20(6):548-54. PubMed ID: 21816613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic options and results for the management of minimally invasive carcinoma of the breast: influence of axillary dissection for treatment of T1a and T1b lesions.
    White RE; Vezeridis MP; Konstadoulakis M; Cole BF; Wanebo HJ; Bland KI
    J Am Coll Surg; 1996 Dec; 183(6):575-82. PubMed ID: 8957459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of surgery with improved survival in stage IV breast cancer patients.
    Blanchard DK; Shetty PB; Hilsenbeck SG; Elledge RM
    Ann Surg; 2008 May; 247(5):732-8. PubMed ID: 18438108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lobular breast cancer: same survival and local control compared with ductal cancer, but should both be treated the same way? analysis of an institutional database over a 10-year period.
    Fortunato L; Mascaro A; Poccia I; Andrich R; Amini M; Costarelli L; Cortese G; Farina M; Vitelli C
    Ann Surg Oncol; 2012 Apr; 19(4):1107-14. PubMed ID: 21913022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgical resection of the primary tumor is associated with increased long-term survival in patients with stage IV breast cancer after controlling for site of metastasis.
    Fields RC; Jeffe DB; Trinkaus K; Zhang Q; Arthur C; Aft R; Dietz JR; Eberlein TJ; Gillanders WE; Margenthaler JA
    Ann Surg Oncol; 2007 Dec; 14(12):3345-51. PubMed ID: 17687611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgery in metastatic breast cancer: patients with a favorable profile seem to have the most benefit from surgery.
    Rashaan ZM; Bastiaannet E; Portielje JE; van de Water W; van der Velde S; Ernst MF; van de Velde CJ; Liefers GJ
    Eur J Surg Oncol; 2012 Jan; 38(1):52-6. PubMed ID: 22032912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of primary tumor extirpation in breast cancer patients who present with stage IV disease and an intact primary tumor.
    Babiera GV; Rao R; Feng L; Meric-Bernstam F; Kuerer HM; Singletary SE; Hunt KK; Ross MI; Gwyn KM; Feig BW; Ames FC; Hortobagyi GN
    Ann Surg Oncol; 2006 Jun; 13(6):776-82. PubMed ID: 16614878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presence of symptoms and timing of surgery do not affect the prognosis of patients with primary metastatic breast cancer.
    Ruiterkamp J; Voogd AC; Bosscha K; Roukema JA; Nieuwenhuijzen GA; Tjan-Heijnen VC; Ernst MF
    Eur J Surg Oncol; 2011 Oct; 37(10):883-9. PubMed ID: 21843923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Omitting axillary lymph node dissection in sentinel node negative breast cancer patients is safe: a long term follow-up analysis.
    Torrenga H; Fabry H; van der Sijp JR; van Diest PJ; Pijpers R; Meijer S
    J Surg Oncol; 2004 Oct; 88(1):4-7; discussion 7-8. PubMed ID: 15384064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Results of conservative surgery for limited-sized infiltrating breast cancer: analysis of 962 tested patients: 24 years of experience.
    Vitucci C; Tirelli C; Graziano F; Santoro E
    J Surg Oncol; 2000 Jun; 74(2):108-15. PubMed ID: 10914819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Locoregional recurrence of breast cancer: a retrospective comparison of treatment methods.
    Skowronek J; Piotrowski T
    Neoplasma; 2002; 49(6):426-31. PubMed ID: 12584593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of breast cancer subtypes on breast cancer specific survival, distant metastases and local relapse rates in conservatively managed early stage breast cancer: a retrospective clinical study.
    Sanpaolo P; Barbieri V; Genovesi D
    Eur J Surg Oncol; 2011 Oct; 37(10):876-82. PubMed ID: 21824742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ratio between positive lymph nodes and total excised axillary lymph nodes as an independent prognostic factor for overall survival in patients with nonmetastatic lymph node-positive breast cancer.
    Hatoum HA; Jamali FR; El-Saghir NS; Musallam KM; Seoud M; Dimassi H; Abbas J; Khalife M; Boulos FI; Tawil AN; Geara FB; Salem Z; Shamseddine AA; Al-Feghali K; Shamseddine AI
    Ann Surg Oncol; 2009 Dec; 16(12):3388-95. PubMed ID: 19655200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up.
    Di Saverio S; Catena F; Santini D; Ansaloni L; Fogacci T; Mignani S; Leone A; Gazzotti F; Gagliardi S; De Cataldis A; Taffurelli M
    Breast Cancer Res Treat; 2008 Jun; 109(3):405-16. PubMed ID: 17687650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Negative margin status improves local control in conservatively managed breast cancer patients.
    Obedian E; Haffty BG
    Cancer J Sci Am; 2000; 6(1):28-33. PubMed ID: 10696736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Breast-conservation treatment for early invasive breast cancer: prognostic factors for survival after salvage treatment of local recurrence].
    Fodor J
    Magy Onkol; 2007; 51(2):127-31. PubMed ID: 17660868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Breast-conserving treatment for early invasive lobular breast cancer: 15 years results].
    Fodor J; Sulyok Z; Polgár C; Major T; Tóth J; Németh G
    Magy Seb; 2001 Aug; 54(4):209-14. PubMed ID: 11550486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Percent positive axillary lymph node metastasis predicts survival in patients with non-metastatic breast cancer.
    Lale Atahan I; Yildiz F; Ozyigit G; Sari S; Gurkaynak M; Selek U; Hayran M
    Acta Oncol; 2008; 47(2):232-8. PubMed ID: 17924207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of residual breast disease and axillary node involvement for patients who had primary induction chemotherapy for advanced breast cancer.
    Escobar PF; Patrick RJ; Rybicki LA; Hicks D; Weng DE; Crowe JP
    Ann Surg Oncol; 2006 Jun; 13(6):783-7. PubMed ID: 16604475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does primary tumor resection improve outcomes for patients with incurable advanced breast cancer?
    Shibasaki S; Jotoku H; Watanabe K; Takahashi M
    Breast; 2011 Dec; 20(6):543-7. PubMed ID: 21775141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.